Markets continue to be sensitive to the coronavirus outbreak. As news of a second potential case in the United States broke, so did markets, leading to the first 1 percent intra-day decline for stocks in months, but at least they closed off their intra-day lows.
| You're receiving this email because you are subscribed to Trading Tips, if you no longer wish to receive these emails you can unsubscribe here. | | | | |
| | Good morning. Markets continue to be sensitive to the coronavirus outbreak. As news of a second potential case in the United States broke, so did markets, leading to the first 1 percent intra-day decline for stocks in months, but at least they closed off their intra-day lows.
With a viral outbreak likely to weigh on economic activity in travel and tourism, expect airline and casino companies to be hard-hit for now, but a potential buying opportunity later. In the meantime, the only asset that seems to consistently rise on these outbreaks is gold as a safe-haven play from market chaos.
| | | | | | | | The NEW biggest-selling drug of all time. How to profit | | | If you're looking to double your money and potentially make 1,000% in gains, then you NEED this biotech stock.
This company has discovered a revolutionary breakthrough in treating heart disease that may end heart attacks and strokes FOREVER! Global demand is skyrocketing and estimated annual sales are a staggering $60 billion. The FDA has all but said it's going to approve the drug. Once that happens, expect the stock price to double in a matter of days.
Get onboard BEFORE the big FDA announcement. Access your FREE report here. | | | | | | | DOW 28,989.73 | -0.58% | | | | S&P 3,295.47 | -0.90% | | | | NASDAQ 9,314.91 | -0.93% | | | | *As of market close | | • | Stocks closed near their lows of the day going into the weekend, as the coronavirus outbreak continued. | | • | Oil dropped 2.1 percent, closing at $54.39 per barrel. | | • | Gold rose 0.36 percent, moving to $1,571 per ounce. | | • | Cryptocurrencies traded mixed, with Bitcoin rising 1 percent to $8,489. | | | | | | | | |
|
|
Two Small-Cap Dividend Plays for Your Portfolio Now | |
|
|
We're fans of dividend paying companies. There's nothing as satisfying as getting regular cash payments, especially during those periods of market uncertainty.
What's more, dividend paying companies are usually more financially conservative, focusing on managing their existing business rather than on growth. While that may scare off growth investors, it doesn't need to.
There are plenty of small-cap plays can offer growth as well as current income now, which makes them attractive bargains in today's environment.
» FULL STORY |
|
|
|
|
| Insider Trading Reports: Dow Inc (DOW) | |
|
|
Richard Davis, a director at Dow Inc (DOW), added 6,000 shares to his holdings. The buy increased his stake by 82 percent. The total cost of the buy came to just over $317,000.
Insider buying data for the past few years shows a mix of buys and sells, with total share buys exceeding sales. Most activity has occurred by directors.
Dow Inc is one of three companies spun off from DowDuPont in April 2019.
» FULL STORY |
|
|
|
|
| Unusual Options Activity: Juniper Networks (JNPR) | |
|
|
March 2020 $23 put options on Juniper Networks (JNPR) saw a 50-fold surge in volume, going from 123 open contracts to over 5,900 trade hands.
The trade, expiring in 53 days, is a bet that shares of the company will fall at least $1.50 from their current price.
For the trader to profit at expiration, shares would need to close in on $22.65, to make up for the cost of $0.45 per contract.
» FULL STORY |
|
|
|
| | |
TOP | | INTC | 8.133% | | | ANET | 3.473% | | | DVA | 3.342% | | | AXP | 2.847% | | | APD | 2.807% | | BOTTOM | | DFS | 11.136% | | | SYF | 9.862% | | | AAP | 5.376% | | | SWKS | 4.587% | | | ORVO | 4.457% | | | |
|
| | |
|
I think America picked the war to fight with China … at really the wrong time. They should have picked the war 10 years ago. Today, China has 1.4 billion people — the world's second largest economy. Who's going to consume more McDonald's and Coca-Cola than China? |
|
- Hong Kong property developer Tan Sri Dato' David Chiu, chairman of Far East Consortium International, on the fragile phase one trade deal between the United States and China, and why the deal may still fall through in the future. |
|
|
| Get in before FDA approval for 10X gains | |
|
This could be the biggest health breakthrough of the decade. FDA approval for a blockbuster new cholesterol drug is just around the corner.
FDA approval can be like rocket fuel for biotech stocks. We've seen stock prices soar 117%, 368%, 626%, 1,100% in mere days. But sadly, most investors don't find out about these huge breakthroughs until AFTER the FDA announces approval.
Most media outlets have yet to report on this life-changing drug breakthrough that could end heart disease and death. Their first story most likely will be the FDA announcement. That's far too late for investors to rack up amazing double-your-money gains.
I have a FREE Special Report on this once-in-a-lifetime opportunity. Investors who act before news of FDA approval could reap windfall profits. This could be the biggest biotech story of 2020. Get the full details here. | |
|
No comments:
Post a Comment